Transient disruption of autocrine TGF-β signaling leads to enhanced survival and proliferation potential in single primitive human hemopoietic progenitor cells

Journal of Immunology

Volumn 168, Issue 2, 2002, Pages 755-762

  Fan, X ^a   Valdimarsdottir, G ^a   Larsson, J ^a   Brun, A ^a   Magnusson, M ^a   Jacobsen, S E ^a   Ten Dijke, P ^a   Karlsson, S ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; AUTOCRINE EFFECT; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE DELIVERY SYSTEM; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0037080204     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.2.755     Document Type: Article

References (44)

1. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
2. 1 phase of the cell cycle
3. Integration of murine leukemia virus DNA depends on mitosis
4. Efficient lentiviral transduction of liver requires cell cycling in vivo
5. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium
6. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood
7. -) human bone marrow progenitor cells: Distinct and key interactions with the ligands for c-kit and flt3 and inhibitory effects of TGF-β and TNF-α
8. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor-β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
9. Transforming growth factor-β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells
10. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-β type II receptor in a short-term in vitro assay
11. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer
12. Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells
13. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-β and tumor necrosis factor-α
14. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor-β-1 or Rb oligonucleotides
15. - human umbilical cord blood cells reveals their potentiality to engraft adults
16. Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-β
17. + peripheral blood progenitors and increases the number of transduced progenitors
18. TGF-β signaling by Smad proteins
19. Specificity, diversity, and regulation in TGF-β superfamily signaling
20. TGF-β signalling from cell membrane to nucleus through SMAD proteins
21. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-β on human hematopoiesis
22. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells
23. Adenoviral vector design for high-level transgene expression in primitive human hematopoietic progenitors
24. A simplified system for generating recombinant adenoviruses
25. Identification of two distinct functions for TGF-β in early mouse development
26. The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying Smad isoform activation
27. TGF-β receptor-mediated signalling through Smad2, Smad3, and Smad4
28. Mouse embryonic stem cells with aberrant transforming growth factor-β signalling exhibit impaired differentiation in vitro and in vivo
29. Expression of a dominant-negative mutant TGF-β type II receptor in transgenic mice reveals essential roles for TGF-β in regulation of growth and differentiation in the exocrine pancreas
30. + hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia
31. Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-β1 is a cell cycle-independent effect and influences their hematopoietic potential
32. - bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin
33. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities
34. Adenovirus-mediated transfer of a truncated transforming growth factor-β (TGF-β) type II receptor completely and specifically abolishes diverse signaling by TGF-β in vascular wall cells in primary culture
35. Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition
36. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma
37. The mouse Pgk-I gene promoter contains an upstream activator sequence
38. Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model
39. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential: Suppression of apoptosis and counteraction by TNF-α and TGF-β
40. Developmentally regulated responsiveness to transforming growth factor-β is correlated with functional differences between human adult and fetal primitive hematopoietic progenitor cells
41. Role of transforming growth factor-β signaling in cancer
42. TGF-β signal transduction
43. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death
44. Activin receptor-like kinase I modulates transforming growth factor-βI signaling in the regulation of angiogenesis